Entourage Health Corp. (ENTG.V)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 150.32 Million CAD | 19.82% |
| 2022 | 125.45 Million CAD | 49.46% |
| 2021 | 83.94 Million CAD | 43.36% |
| 2020 | 58.55 Million CAD | 47.8% |
| 2019 | 39.61 Million CAD | 286.67% |
| 2018 | -21.22 Million CAD | -59.09% |
| 2017 | -13.34 Million CAD | -332.13% |
| 2016 | 5.74 Million CAD | 1028.62% |
| 2015 | -618.9 Thousand CAD | 12.45% |
| 2014 | -706.92 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 158.66 Million CAD | 5.54% |
| 2024 Q2 | 172.08 Million CAD | 8.46% |
| 2023 Q4 | 150.32 Million CAD | 3.04% |
| 2023 FY | 150.32 Million CAD | 19.82% |
| 2023 Q1 | 138.57 Million CAD | 10.46% |
| 2023 Q2 | 139.5 Million CAD | 0.67% |
| 2023 Q3 | 145.89 Million CAD | 4.58% |
| 2022 Q2 | 102.12 Million CAD | 5.99% |
| 2022 Q4 | 125.45 Million CAD | 12.59% |
| 2022 FY | 125.45 Million CAD | 49.46% |
| 2022 Q1 | 96.35 Million CAD | 14.78% |
| 2022 Q3 | 111.43 Million CAD | 9.11% |
| 2021 Q3 | 68.38 Million CAD | 7.5% |
| 2021 FY | 83.94 Million CAD | 43.36% |
| 2021 Q1 | 59.16 Million CAD | 1.04% |
| 2021 Q2 | 63.61 Million CAD | 7.52% |
| 2021 Q4 | 83.94 Million CAD | 22.75% |
| 2020 Q4 | 58.55 Million CAD | 18.44% |
| 2020 FY | 58.55 Million CAD | 47.8% |
| 2020 Q3 | 49.44 Million CAD | 14.69% |
| 2020 Q2 | 43.1 Million CAD | 25.78% |
| 2020 Q1 | 34.27 Million CAD | -13.49% |
| 2019 Q3 | 31.73 Million CAD | 27.48% |
| 2019 FY | 39.61 Million CAD | 286.67% |
| 2019 Q4 | 39.61 Million CAD | 24.84% |
| 2019 Q1 | 15.46 Million CAD | 172.87% |
| 2019 Q2 | 24.89 Million CAD | 60.96% |
| 2018 Q4 | -21.22 Million CAD | 37.02% |
| 2018 FY | -21.22 Million CAD | -59.09% |
| 2018 Q3 | -33.69 Million CAD | 10.06% |
| 2018 Q1 | -39.84 Million CAD | -198.68% |
| 2018 Q2 | -37.46 Million CAD | 5.97% |
| 2017 Q1 | 1.89 Million CAD | -67.01% |
| 2017 Q2 | -3.96 Million CAD | -309.28% |
| 2017 Q3 | -2.74 Million CAD | 30.8% |
| 2017 Q4 | -13.34 Million CAD | -385.82% |
| 2017 FY | -13.34 Million CAD | -332.13% |
| 2016 FY | 5.74 Million CAD | 1028.62% |
| 2016 Q4 | 5.74 Million CAD | 1008.2% |
| 2016 Q2 | -643.89 Thousand CAD | 4.03% |
| 2016 Q1 | -670.91 Thousand CAD | -8.4% |
| 2016 Q3 | -632.82 Thousand CAD | 1.72% |
| 2015 Q4 | -618.9 Thousand CAD | 10.85% |
| 2015 Q3 | -694.2 Thousand CAD | 0.09% |
| 2015 FY | -618.9 Thousand CAD | 12.45% |
| 2015 Q2 | -694.82 Thousand CAD | 0.84% |
| 2015 Q1 | -700.67 Thousand CAD | 0.88% |
| 2014 Q4 | -706.92 Thousand CAD | -229.42% |
| 2014 FY | -706.92 Thousand CAD | 0.0% |
| 2014 Q3 | -214.59 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 4.89 Million CAD | -2971.945% |
| CanadaBis Capital Inc. | 4.08 Million CAD | -3580.799% |
| Decibel Cannabis Company Inc. | 37.48 Million CAD | -301.057% |
| Delivra Health Brands Inc. | -2.17 Million CAD | 7017.995% |
| Lifeist Wellness Inc. | -188.12 Thousand CAD | 80006.889% |
| Cannara Biotech Inc. | 41.51 Million CAD | -262.124% |
| Medicure Inc. | -5.82 Million CAD | 2680.739% |
| PharmaCielo Ltd. | 18.24 Million CAD | -723.874% |
| Rubicon Organics Inc. | 475.37 Thousand CAD | -31523.241% |
| BioSyent Inc. | -3.68 Million CAD | 4179.492% |
| Voyageur Pharmaceuticals Ltd. | 37.91 Thousand CAD | -396386.963% |